Cargando…
Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis
Autores principales: | Soriano, María Cruz, Narváez-Chávez, Gabriela, López-Olivencia, Marina, Fortún, Jesús, de Pablo, Raúl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697542/ https://www.ncbi.nlm.nih.gov/pubmed/34940907 http://dx.doi.org/10.1007/s00134-021-06603-y |
Ejemplares similares
-
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic
Disease: An Update
por: Duckwall, Madison J, et al.
Publicado: (2019) -
Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis
por: Shirkhani, Khojasteh, et al.
Publicado: (2015) -
Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection
por: Fortún, Jesús, et al.
Publicado: (2023) -
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
por: Van Ackerbroeck, Sofie, et al.
Publicado: (2021) -
Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
por: Hamada, Noboru, et al.
Publicado: (2021)